FORT MYERS, Fla. and FREMONT, Calif. — NeoGenomics, Inc. (Nasdaq:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, Inc., a developer of a revolutionary ultra-high throughput next-generation sequencing (NGS) platform, today announced a collaboration to use Ultima’s UG 100™ sequencing platform and its ppmSeq™ technology to advance NeoGenomics’ ability to offer innovative clinical tests. […]

Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of Combination BILLERICA, Mass. and MARLBOROUGH, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced an amendment to the terms of their previously announced merger agreement. Under the amended terms, Quanterix will issue approximately 7.76 […]

Launched with 300 million cells and growing, Arc’s collection of computation-ready, single-cell measurements is getting a boost from 10x and Ultima technologies Arc Institute continues its work to generate and share large-scale, high-quality datasets of cell state before and after chemical or genetic perturbations to enable “virtual cell” models and other innovations. Two months after […]

SAN DIEGO — CS Genetics, a leader in single cell genomics, is proud to announce the appointment of Paul McEwan as an Independent Director to its Board. Mr. McEwan brings over two decades of experience in life science tools, genomics, and strategic growth. Mr. McEwan is a serial entrepreneur in the life sciences sector, with a proven track […]

BOSTON — Volta Labs, Inc. today announced the launch of the Volta Access Program, a new initiative aimed at increasing access to its Callisto™ Sample Prep System for academic research institutions in the U.S. facing tightening capital budgets. Selected applicants will be able to access Callisto for $4,950 per month over a 24-month term, with full service support and no […]

Company licenses novel deep learning-based epigenetic models from CUHK enabling the detection of 5hmC, 5mC hemimethylation, and 6mA in standard sequencing runs MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced it plans to improve on its already highly accurate methylation detection capabilities in HiFi chemistry through […]

CHICAGO — Complete Genomics, a leading innovator in genomic sequencing announced a collaboration with Velsera, a leading global healthcare technology company, to deliver an end-to-end genetic testing solution that integrates DNBSEQ™ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW) data analysis solution. The partnership, announced this week at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, will accelerate and streamline the […]

Combines BioSkryb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine Durham, NC and Männedorf, Switzerland – BioSkryb Genomics and Tecan […]

Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine Durham, NC and Männedorf, Switzerland – BioSkryb Genomics and Tecan […]

Advancements include CosMx® 2.0 upgrade; CosMx same-slide multiomics; and multiomics capabilities on the nCounter® platform CHICAGO — Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American Association for Cancer Research (AACR) General Meeting. These new advancements build upon the innovations announced at AGBT, […]